These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23345188)

  • 21. Clinical psychopharmacy consultations: acceptance of recommendations on an adult inpatient psychiatric unit.
    Morton WA; Mendenhall AR; Windsor PG; Lydiard B
    Hosp Pharm; 1995 Sep; 30(9):786-90. PubMed ID: 10151283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interventions by clinical pharmacists on surgical wards - impact on antibiotic therapy].
    Weber A; Schneider C; Grill E; Strobl R; Vetter-Kerkhoff C; Jauch KW
    Zentralbl Chir; 2011 Feb; 136(1):66-73. PubMed ID: 21337293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
    Belaiche S; Romanet T; Allenet B; Calop J; Zaoui P
    J Nephrol; 2012; 25(5):782-8. PubMed ID: 22322820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotropic drug versus psychotropic drug-update.
    Strain JJ; Chiu NM; Sultana K; Karim A; Caliendo G; Mustafa S; Strain JJ
    Gen Hosp Psychiatry; 2004; 26(2):87-105. PubMed ID: 15038926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention].
    Hahn M; Braus DF
    Versicherungsmedizin; 2012 Sep; 64(3):127-31. PubMed ID: 22997674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspective: Upcoming paradigm shifts for psychiatry in clinical care, research, and education.
    Rubin EH; Zorumski CF
    Acad Med; 2012 Mar; 87(3):261-5. PubMed ID: 22373615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
    Grohmann R; Ströbel C; Rüther E; Dirschedl P; Helmchen H; Hippius H; Müller-Oerlinghausen B; Schmidt LG; Wolf B
    Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polypharmacy and geriatric psychiatry].
    Hamzaoui A; Joulié A; El Dachri Y
    Soins Gerontol; 2017; 22(127):17-21. PubMed ID: 28917331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic drug therapy knowledge of health care practitioners.
    Weiner J; Schumacher GE
    Am J Hosp Pharm; 1976 Mar; 33(3):237-41. PubMed ID: 1258883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential drug-drug interactions on a tertiary-care hospital consultation-liaison psychiatry service.
    Adson DE; Crow SJ; Meller WH; Magraw RM
    Psychosomatics; 1998; 39(4):360-5. PubMed ID: 9691705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interactions between various psychopharmaceuticals].
    Eben A
    MMW Fortschr Med; 2006 Nov; 148(46):36-8. PubMed ID: 17615786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions in psychopharmacology.
    Callahan AM; Fava M; Rosenbaum JF
    Psychiatr Clin North Am; 1993 Sep; 16(3):647-71. PubMed ID: 8415238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment.
    Nicolson SE; Caplan JP; Williams DE; Stern TA
    Harv Rev Psychiatry; 2009; 17(6):407-20. PubMed ID: 19968455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A framework to avoid irrational polypharmacy in psychiatry.
    Zigman D; Blier P
    J Psychopharmacol; 2012 Dec; 26(12):1507-11. PubMed ID: 22767374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of clinical-pharmacological recommendations in psychiatry in Germany.
    Schröder S; Schulze Westhoff M; Pfister T; Bleich S; Wedegärtner F; Krüger TH; Heck J; Groh A
    Int J Psychiatry Med; 2024 May; 59(3):393-405. PubMed ID: 37194304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients.
    Rivkin A; Yin H
    J Crit Care; 2011 Feb; 26(1):104.e1-6. PubMed ID: 20646898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.